NRAS and acute myeloid leukemia: Moreover, increased NRAS expression was also found in AML patients compared with controls (median 4.896 vs 2.838) (P=0.044, Figure 1B), and identified in 37/143 (26%) of AML patients based on the cut-off value (defined as mean+2SD in controls).